atypical symptoms including chest pain and extra oesophageal complaints Retrospective 58 patients Inclusion: Index test: Technical efficacy: Sofi et al. () case series Age range: 26–87 years Not stated System: Bravo™ wireless capsule system Early detachment (none) Department of 17 males, 41 females Exclusion: Insertion: transorally Device malfunction Gastroenterology, Not stated Placement: 6 cm above the GOJ Recording failure University of Toledo Comparator: NA Medical Center, Toledo, Ohio, USA Tankurt et al. () Case series 64 patients (37 males, 27 Inclusion: Index test: Technical efficacy: females) Not stated System: Bravo™ wireless capsule system Early detachment Kent Hospital, Mean age: 37.9 years (range Department of Level: IV Exclusion: Insertion: NS 25–58) Gastroenterology, Quality: Q2 Not stated Placement: 6 cm above the SCJ Izmir, Turkey Indications: CX (no Duration: 48 hours Preoperative evaluation (17), comparator) evaluation of atypical reflux P2 Comparator: NA symptoms (40) and ‘other’ (7) Tseng et al. () Retrospective 190 procedures and 186 Inclusion: Index test: Technical efficacy: case series patients (some had the test Patients older than 18 years System: Bravo™ wireless capsule system Loss of signal/data Digestive Health performed twice) Center, Department Insertion: transnasally or transorally Early detachment 72 males and 114 females of Surgery and Level: IV Exclusion: Placement: 5–6cm above the LOS or 5–6 m Day-to-day variability Division of Mean age: 51 years Quality: Q1 above the SCJ Not stated Gastroenterology, CX (no Duration: 48 hours Oregon health and comparator) Indication: Science University, P2 Being evaluated for GORD Comparator: Portland, Oregon, 24-hour Bravo monitoring USA Tu et al. () Prospective case 30 patients Inclusion: Index test: Technical efficacy: series 20 males, 10 females Not stated System: Bravo™ wireless capsule system Attachment failure Department of Internal Medicine Mean age: 57.6 ± 14.3 years Exclusion: Insertion: transorally and Department of Level: IV (range 29–83) Not stated Placement: 6 cm proximal to the GOJ Emergency Quality: Q1 Indications: Duration: 48 hours Medicine, National CX (no 24 patients with GORD were
atypical symptoms including chest pain and extra oesophageal complaints Sofi et al. () Department of Gastroenterology, University of Toledo Medical Center, Toledo, Ohio, USA Retrospective case series 58 patients Age range: 26–87 years 17 males, 41 females Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: transorally Placement: 6 cm above the GOJ Comparator: NA Technical efficacy: Early detachment (none) Device malfunction Recording failure Tankurt et al. () Kent Hospital, Department of Gastroenterology, Izmir, Turkey Case series Level: IV Quality: Q2 CX (no comparator) P2 64 patients (37 males, 27 females) Mean age: 37.9 years (range 25–58) Indications: Preoperative evaluation (17), evaluation of atypical reflux symptoms (40) and ‘other’ (7) Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: NS Placement: 6 cm above the SCJ Duration: 48 hours Comparator: NA Technical efficacy: Early detachment Tseng et al. () Digestive Health Center, Department of Surgery and Division of Gastroenterology, Oregon health and Science University, Portland, Oregon, USA Retrospective case series Level: IV Quality: Q1 CX (no comparator) P2 190 procedures and 186 patients (some had the test performed twice) 72 males and 114 females Mean age: 51 years Indication: Being evaluated for GORD Inclusion: Patients older than 18 years Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: transnasally or transorally Placement: 5–6cm above the LOS or 5–6 m above the SCJ Duration: 48 hours Comparator: 24-hour Bravo monitoring Technical efficacy: Loss of signal/data Early detachment Day-to-day variability Tu et al. () Department of Internal Medicine and Department of Emergency Medicine, National Prospective case series Level: IV Quality: Q1 CX (no 30 patients 20 males, 10 females Mean age: 57.6 ± 14.3 years (range 29–83) Indications: 24 patients with GORD were Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: transorally Placement: 6 cm proximal to the GOJ Duration: 48 hours Technical efficacy: Attachment failure
1203-ContractedAssessmentReport-Catheter-free%20ambulatory%20pH%20test%20for%20GORD%20accessible.docx